// App-Quantinova.ai

: Do higher quantitative interferon gamma release assay or tuberculin skin test results help to predict incident tuberculosis? Data from the UK PREDICT study

Researchers

Presenter

  • Rishi Gupta

Principal Investigators

  • Marc Lipman

  • Charlotte Jackson

  • Alice Sitch

  • Jo Southern

  • Francis Drobniewski

  • Jonathan Deeks

  • Chuen-Yan Tsou

  • Chris Griffiths

  • Jennifer Davidson

  • Colin Campbell

  • Oliver Stirrup

  • Mahdad Noursadeghi

  • Heinke Kunst

  • Pranab Haldar

  • Ajit Lalvani

  • Ibrahim Abubakar

Medical Centers

  • Institute of Neurology, University College London, London, United Kingdom

  • UCL Respiratory, University College London, London, United Kingdom

  • Institute of Child Health, University of Birmingham, Birmingham, United Kingdom

  • Public Health England, TB Unit, Colindale, London, United Kingdom

  • Section of Infectious Diseases, Imperial College London, London, United Kingdom

  • Barts Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom

  • Department of Infection and Immunity, University College London, London, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Respiratory Biomedical Research Centre, Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom

  • Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Interferon Gamma

  • Tuberculin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved